Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
49
datasets available to search
ShareScore release 0.9.0
Dataset results
49 results for “ozanimod”
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03467958. IPD Sharing: Not stated. Countries: 49. Publications: 1.
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT02047734. IPD Sharing: Not stated. Countries: 21. Publications: 2.
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03440372. IPD Sharing: Not stated. Countries: 35. Publications: 1.
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT02294058. IPD Sharing: Not stated. Countries: 25. Publications: 3.
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
ClinicalTrials.gov study NCT01628393. IPD Sharing: Not stated. Countries: 13. Publications: 2.
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03464097. IPD Sharing: Not stated. Countries: 49. Publications: 1.
Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
ClinicalTrials.gov study NCT01647516. IPD Sharing: Not stated. Countries: 15. Publications: 2.
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03440385. IPD Sharing: Not stated. Countries: 31. Publications: 1.
Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects
ClinicalTrials.gov study NCT06528665. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)
ClinicalTrials.gov study NCT05335031. IPD Sharing: NO. Countries: 1. Publications: 1.
Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study
ClinicalTrials.gov study NCT05245344. IPD Sharing: NO. Countries: 1. Publications: 32.
Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A
ClinicalTrials.gov study NCT03624959. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate
ClinicalTrials.gov study NCT03644576. IPD Sharing: Not stated. Countries: 1. Publications: 1.
COVID-19 Ozanimod Intervention Study
ClinicalTrials.gov study NCT04405102. IPD Sharing: NO. Countries: 1. Publications: 1.
Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
ClinicalTrials.gov study NCT05319093. IPD Sharing: NO. Countries: 1. Publications: 17.
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03915769. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifyin
ClinicalTrials.gov study NCT05028634. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Ther
ClinicalTrials.gov study NCT05470985. IPD Sharing: Not stated. Countries: 9. Publications: 0.
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
ClinicalTrials.gov study NCT05369832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT05644665. IPD Sharing: YES. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.